Same Indication

Imatinib vs Metformin

Imatinib vs Metformin: Overview

This comparison examines the pharmacological differences between Imatinib and Metformin.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Metformin — 4-9 hours.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O; Metformin — C4H11N5.

Molecular Weight: Imatinib — 493.6030 g/mol; Metformin — 129.1640 g/mol.

Type: Imatinib — Small molecule; Metformin — Small molecule.